Oxford BioMedica plc  

(Public, LON:OXB)   Watch this stock  
Find more results for OXB
7.02
+0.02 (0.29%)
Jan 30 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 6.82 - 7.03
52 week 1.77 - 10.12
Open 6.93
Vol / Avg. 2.05M/6.56M
Mkt cap 180.13M*
P/E     -
Div/yield     -
EPS -0.01*
Shares 2.57B
Beta     -
Inst. own     -
*GBP
Jan 13, 2015
Oxford BioMedica PLC at EBD Biotech Showcase
Nov 21, 2014
Oxford BioMedica PLC Interim Management Statement (Estimated)
  

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -101.57% -206.44%
Operating margin -114.62% -238.57%
EBITD margin - -218.72%
Return on average assets -43.98% -58.30%
Return on average equity -57.70% -77.75%
Employees 95 -
CDP Score - -

Address

The Oxford Science Park Medawar Centre Robert Robinson Avenue
OXFORD, OX4 4GA
United Kingdom - Map
+44-1865-783000 (Phone)
+44-1865-783001 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Oxford Biomedica PLC is a United Kingdom-based biopharmaceutical company. The Company is engaged in advanced therapy medicinal products. The Company designs, develops and manufactures gene-based medicines and therapeutic vaccines. The Company's technology platform includes LentiVector gene delivery technology, which has specific advantages for targeting diseases of the eye and central nervous system and a tumour antigen (5T4), which is a target for anti-cancer therapy. Its product pipeline addresses diseases, including ocular diseases, neurodegenerative disorders and cancer.

Officers and directors

John Dawson Chief Executive Officer, Executive Director
Age: 54
Tim Watts Chief Financial Officer, Company Secretary, Executive Director
Age: 56
Peter Nolan Senior Vice President - Commercial Development, Executive Director
Age: 60
Paul Blake M.D. Chief Development Officer, Director
Age: 66
Nick Rodgers Non-Executive Independent Chairman of the Board
Age: 55
Andrew J. Heath M.D., Ph.D. Non-Executive Deputy Chairman of the Board, Senior Independent Director
Age: 64
Martin Diggle Non-Executive Director
Age: 52